![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, May 15, 2012 7:00:16 PM
For now, however, I believe we are in for 2-3 years of little real stock movement. Witness the recent momentary 'pop' we got out of the patent approval. A significant event and we got a 3 day bump and back to the .60s. We'll get another little 'pop' when and if the FDA permits the IND process to start. And other small spikes and retreats as we move through that process. But nothing really significant can be expected until there are results from human trials and that will take several years. Meantime, if we get back up to $2-3 ps in the next two years, we will be very fortunate.
So to my mind, this stock is all about patience, buying for your core position when it's very cheap and selling your most expensive shares when it's up. And to bide the time, you can trade it. I recently bought a trading block of shares at .56 and sold at .75. Yes, I left money on the table, but a 34% gain soothed the pain and lowered my overall basis. This time I will be looking at buying in the low .60s, probably around .62 or so, with a sale around .80. Wash, rinse and repeat.
Here's an objective for you: Can you trade successfully enough to get your basis on your core position down below zero? Beats carping about how the stock isn't going anywhere, when you know it won't for several years.
My plan: Pay attention to what is happening, but don't get to worked up about the pps. Make it work for you while you wait. And be prepared to wait a long while.
Recent NNVC News
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
Peer To Peer Network aka Mobicard™ Launches AI Investor Chatbot Boosting Engagement & Lead Generation on Ihub • PTOP • Jul 15, 2024 8:30 AM
Greenlite Ventures Announces AI Integration into No Limit Platforms • GRNL • Jul 15, 2024 8:00 AM
Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • BLO • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM